HSP 32.37 0.40 / Hospira, Inc. FDA | Benzinga

Friday, December 30, 2011

ETF Showdown: Fun With Pharma (ABT, AGN, AZN, HSP, JAZZ, JNJ, LLY, Long Ideas, MRK, MYL, News, PFE, PPH, Sector ETFs, SLXP, XPH, Short Ideas, New ETFs, FDA, After-Hours Center, Markets, Movers, Trading Ideas, ETFs / Fri, 05:10pm)

Tuesday, September 06, 2011

Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients (HSP, News, FDA / Tue, 12:37pm)

Friday, August 05, 2011

Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection (HSP, News, FDA / Fri, 11:33am)

Friday, May 20, 2011

Hospira Receives Health Canada Regulatory Approval for Symbiq Infusion System Software Upgrade (HSP, News, FDA / Fri, 12:17pm)

Monday, April 04, 2011

Hospira Submits 510(k) Application to FDA for Symbiq Infusion System Modifications (HSP, News, FDA / Mon, 10:15am)

Wednesday, March 09, 2011

Hospira Announces U.S. Approval of Generic Docetaxel (HSP, News, FDA / Wed, 10:46am)

Thursday, February 03, 2011

Hospira Receives FDA Approval of Topotecan Injection (HSP, News, FDA / Thu, 01:02pm)

Monday, November 15, 2010

Hospira Launches Gemcitabine HCL (HSP, LLY, News, FDA / Mon, 03:48pm)

Wednesday, June 16, 2010

13 Drugs Facing FDA Approval Decisions (HGSI, HSP, JAV, JNJ, News, FDA, Markets / Wed, 08:43am)

Wednesday, May 19, 2010

J.P. Morgan Endorses Teva And Hospira Stock (JOM, TEVA, HSP) (Analyst Color, HSP, JPM, Long Ideas, MYL, News, TEVA, WPI, FDA, Intraday Update, Analyst Ratings, Trading Ideas / Wed, 06:06pm)